Page last updated: 2024-10-30

losartan and Intellectual Disability

losartan has been researched along with Intellectual Disability in 2 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cappuccio, G1
Caiazza, M1
Roca, A1
Melis, D2
Iuliano, A1
Matyas, G1
Rubino, M1
Limongelli, G1
Brunetti-Pierri, N2
Piccolo, P1
Mithbaokar, P1
Sabatino, V1
Tolmie, J1
Schiaffino, MC1
Filocamo, M1
Andria, G1

Trials

1 trial available for losartan and Intellectual Disability

ArticleYear
A pilot clinical trial with losartan in Myhre syndrome.
    American journal of medical genetics. Part A, 2021, Volume: 185, Issue:3

    Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Child; Child, Preschool; Cryptorchidism;

2021

Other Studies

1 other study available for losartan and Intellectual Disability

ArticleYear
SMAD4 mutations causing Myhre syndrome result in disorganization of extracellular matrix improved by losartan.
    European journal of human genetics : EJHG, 2014, Volume: 22, Issue:8

    Topics: Adolescent; Adult; Child; Cryptorchidism; Extracellular Matrix; Facies; Female; Fibroblasts; Growth

2014